Metabolic Syndrome and Its Potential Effect on Treatment Response to Aripiprazole A Post Hoc Analysis of the Stabilization Phase of a Long-Term, Double-Blind Study in Patients With Bipolar Disorder (CN138-010)

Ähnliche Einträge

• A 52-Week, Double-Blind Evaluation of the Metabolic Effects of Aripiprazole and Lithium in Bipolar I Disorder
  von: McIntyre, Roger S., et al.
  Veröffentlicht: (2011)
• Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study
  von: Muzina, D J, et al.
  Veröffentlicht: (2008)
• Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163)
  von: Nelson, J. Craig, et al.
  Veröffentlicht: (2009)
• Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder
  von: Kemp, David E, et al.
  Veröffentlicht: (2010)
• Effects of Adjunctive Aripiprazole on Sexual Functioning in Patients With Major Depressive Disorder and an Inadequate Response to Standard Antidepressant Monotherapy: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Studies
  von: Fava, Maurizio, et al.
  Veröffentlicht: (2011)